FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Jan 2002. Module: SNOMED CT model component

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Case sensitive SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym Active Case sensitive SNOMED CT model component


131244 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set Is a Historical association true Inferred relationship Some

Members associationTargetComponent
Actemra (tocilizumab 162 mg / 0.9 mL) injection solution, 0.9 mL syringe (trade product unit of use) Unknown Cell Type 2
Actemra (tocilizumab 162 mg / 0.9 mL) injection solution, 1 x 0.9 mL syringe (containered trade product pack) Unknown Cell Type 2
Actemra (tocilizumab 162 mg / 0.9 mL) injection solution, 1 x 0.9 mL syringe (trade product pack) Unknown Cell Type 2
Actemra (tocilizumab 162 mg / 0.9 mL) injection solution, 4 x 0.9 mL syringes (containered trade product pack) Unknown Cell Type 2
Actemra (tocilizumab 162 mg / 0.9 mL) injection solution, 4 x 0.9 mL syringes (trade product pack) Unknown Cell Type 2
Actemra (tocilizumab 200 mg / 10 mL) concentrated injection, 1 x 10 mL vial (containered trade product pack) Unknown Cell Type 2
Actemra (tocilizumab 200 mg / 10 mL) concentrated injection, 1 x 10 mL vial (trade product pack) Unknown Cell Type 2
Actemra (tocilizumab 200 mg / 10 mL) concentrated injection, 10 mL vial (trade product unit of use) Unknown Cell Type 2
Actemra (tocilizumab 200 mg / 10 mL) concentrated injection, 4 x 10 mL vials (containered trade product pack) Unknown Cell Type 2
Actemra (tocilizumab 200 mg / 10 mL) concentrated injection, 4 x 10 mL vials (trade product pack) Unknown Cell Type 2
Actemra (tocilizumab 400 mg / 20 mL) concentrated injection, 1 x 20 mL vial (containered trade product pack) Unknown Cell Type 2
Actemra (tocilizumab 400 mg / 20 mL) concentrated injection, 1 x 20 mL vial (trade product pack) Unknown Cell Type 2
Actemra (tocilizumab 400 mg / 20 mL) concentrated injection, 20 mL vial (trade product unit of use) Unknown Cell Type 2
Actemra (tocilizumab 400 mg / 20 mL) concentrated injection, 4 x 20 mL vials (containered trade product pack) Unknown Cell Type 2
Actemra (tocilizumab 400 mg / 20 mL) concentrated injection, 4 x 20 mL vials (trade product pack) Unknown Cell Type 2
Actemra (tocilizumab 80 mg / 4 mL) concentrated injection, 1 x 4 mL vial (containered trade product pack) Unknown Cell Type 2
Actemra (tocilizumab 80 mg / 4 mL) concentrated injection, 1 x 4 mL vial (trade product pack) Unknown Cell Type 2
Actemra (tocilizumab 80 mg / 4 mL) concentrated injection, 4 mL vial (trade product unit of use) Unknown Cell Type 2
Actemra (tocilizumab 80 mg / 4 mL) concentrated injection, 4 x 4 mL vials (containered trade product pack) Unknown Cell Type 2
Actemra (tocilizumab 80 mg / 4 mL) concentrated injection, 4 x 4 mL vials (trade product pack) Unknown Cell Type 2
Actemra 162 mg/0.9 mL injection solution, 0.9 mL syringe Unknown Cell Type 2
Actemra 162 mg/0.9 mL injection solution, 0.9 mL syringe Unknown Cell Type 2
Actemra 162 mg/0.9 mL injection solution, 0.9 mL syringe Unknown Cell Type 2
Actemra 162 mg/0.9 mL injection solution, 4 x 0.9 mL syringes Unknown Cell Type 2
Actemra 162 mg/0.9 mL injection solution, 4 x 0.9 mL syringes Unknown Cell Type 2
Actemra 200 mg/10 mL concentrated injection, 10 mL vial Unknown Cell Type 2
Actemra 200 mg/10 mL concentrated injection, 10 mL vial Unknown Cell Type 2
Actemra 200 mg/10 mL concentrated injection, 10 mL vial Unknown Cell Type 2
Actemra 200 mg/10 mL concentrated injection, 4 x 10 mL vials Unknown Cell Type 2
Actemra 200 mg/10 mL concentrated injection, 4 x 10 mL vials Unknown Cell Type 2
Actemra 400 mg/20 mL concentrated injection, 20 mL vial Unknown Cell Type 2
Actemra 400 mg/20 mL concentrated injection, 20 mL vial Unknown Cell Type 2
Actemra 400 mg/20 mL concentrated injection, 20 mL vial Unknown Cell Type 2
Actemra 400 mg/20 mL concentrated injection, 4 x 20 mL vials Unknown Cell Type 2
Actemra 400 mg/20 mL concentrated injection, 4 x 20 mL vials Unknown Cell Type 2
Actemra 80 mg/4 mL concentrated injection, 4 mL vial Unknown Cell Type 2
Actemra 80 mg/4 mL concentrated injection, 4 mL vial Unknown Cell Type 2
Actemra 80 mg/4 mL concentrated injection, 4 mL vial Unknown Cell Type 2
Actemra 80 mg/4 mL concentrated injection, 4 x 4 mL vials Unknown Cell Type 2
Actemra 80 mg/4 mL concentrated injection, 4 x 4 mL vials Unknown Cell Type 2
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection solution, 0.9 mL injection device (trade product unit of use) Unknown Cell Type 2
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection solution, 1 x 0.9 mL injection device (containered trade product pack) Unknown Cell Type 2
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection solution, 1 x 0.9 mL injection device (trade product pack) Unknown Cell Type 2
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection solution, 4 x 0.9 mL injection devices (containered trade product pack) Unknown Cell Type 2
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection solution, 4 x 0.9 mL injection devices (trade product pack) Unknown Cell Type 2
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection, 0.9 mL injection device (trade product unit of use) Unknown Cell Type 2
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection, 1 x 0.9 mL injection device (containered trade product pack) Unknown Cell Type 2
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection, 1 x 0.9 mL injection device (trade product pack) Unknown Cell Type 2
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection, 4 x 0.9 mL injection devices (containered trade product pack) Unknown Cell Type 2
Actemra Actpen (tocilizumab 162 mg / 0.9 mL) injection, 4 x 0.9 mL injection devices (trade product pack) Unknown Cell Type 2
Actemra Actpen 162 mg/0.9 mL injection solution, 0.9 mL injection device Unknown Cell Type 2
Actemra Actpen 162 mg/0.9 mL injection solution, 0.9 mL injection device Unknown Cell Type 2
Actemra Actpen 162 mg/0.9 mL injection solution, 0.9 mL injection device Unknown Cell Type 2
Actemra Actpen 162 mg/0.9 mL injection solution, 4 x 0.9 mL injection devices Unknown Cell Type 2
Actemra Actpen 162 mg/0.9 mL injection solution, 4 x 0.9 mL injection devices Unknown Cell Type 2
Actemra Actpen 162 mg/0.9 mL injection, 0.9 mL injection device Unknown Cell Type 2
Actemra Actpen 162 mg/0.9 mL injection, 0.9 mL injection device Unknown Cell Type 2
Actemra Actpen 162 mg/0.9 mL injection, 0.9 mL injection device Unknown Cell Type 2
Actemra Actpen 162 mg/0.9 mL injection, 4 x 0.9 mL injection devices Unknown Cell Type 2
Actemra Actpen 162 mg/0.9 mL injection, 4 x 0.9 mL injection devices Unknown Cell Type 2
Actifed CC Chesty Cough (guaifenesin 100 mg / 5 mL) oral liquid solution, 100 mL (trade product pack) Unknown Cell Type 2
Actifed CC Chesty Cough (guaifenesin 100 mg / 5 mL) oral liquid solution, 100 mL, bottle (containered trade product pack) Unknown Cell Type 2
Actifed CC Chesty Cough (guaifenesin 100 mg / 5 mL) oral liquid solution, 200 mL (trade product pack) Unknown Cell Type 2
Actifed CC Chesty Cough (guaifenesin 100 mg / 5 mL) oral liquid solution, 200 mL, bottle (containered trade product pack) Unknown Cell Type 2
Actifed CC Chesty Cough (guaifenesin 100 mg / 5 mL) oral liquid solution, 30 mL (trade product pack) Unknown Cell Type 2
Actifed CC Chesty Cough (guaifenesin 100 mg / 5 mL) oral liquid solution, 30 mL, bottle (containered trade product pack) Unknown Cell Type 2
Actifed CC Chesty Cough (guaifenesin 100 mg / 5 mL) oral liquid solution, 5 mL measure (trade product unit of use) Unknown Cell Type 2
Actifed CC Chesty Cough (guaiphenesin 100 mg / 5 mL) oral liquid solution, 100 mL Unknown Cell Type 2
Actifed CC Chesty Cough (guaiphenesin 100 mg / 5 mL) oral liquid solution, 100 mL, bottle Unknown Cell Type 2
Actifed CC Chesty Cough (guaiphenesin 100 mg / 5 mL) oral liquid solution, 200 mL Unknown Cell Type 2
Actifed CC Chesty Cough (guaiphenesin 100 mg / 5 mL) oral liquid solution, 200 mL, bottle Unknown Cell Type 2
Actifed CC Chesty Cough (guaiphenesin 100 mg / 5 mL) oral liquid solution, 30 mL Unknown Cell Type 2
Actifed CC Chesty Cough (guaiphenesin 100 mg / 5 mL) oral liquid solution, 30 mL, bottle Unknown Cell Type 2
Actifed CC Chesty Cough (guaiphenesin 100 mg / 5 mL) oral liquid solution, 5 mL measure Unknown Cell Type 2
Actifed CC Chesty Cough 100 mg/5 mL oral liquid solution, 100 mL Unknown Cell Type 2
Actifed CC Chesty Cough 100 mg/5 mL oral liquid solution, 100 mL, bottle Unknown Cell Type 2
Actifed CC Chesty Cough 100 mg/5 mL oral liquid solution, 200 mL Unknown Cell Type 2
Actifed CC Chesty Cough 100 mg/5 mL oral liquid solution, 200 mL, bottle Unknown Cell Type 2
Actifed CC Chesty Cough 100 mg/5 mL oral liquid solution, 30 mL Unknown Cell Type 2
Actifed CC Chesty Cough 100 mg/5 mL oral liquid solution, 30 mL, bottle Unknown Cell Type 2
Actifed CC Chesty Cough 100 mg/5 mL oral liquid solution, 5 mL Unknown Cell Type 2
Actifed CC Dry Cough (pholcodine 1 mg / 1 mL) oral liquid solution, 1 mL measure (trade product unit of use) Unknown Cell Type 2
Actifed CC Dry Cough (pholcodine 1 mg / 1 mL) oral liquid solution, 200 mL (trade product pack) Unknown Cell Type 2
Actifed CC Dry Cough (pholcodine 1 mg / 1 mL) oral liquid solution, 200 mL, bottle (containered trade product pack) Unknown Cell Type 2
Actifed CC Dry Cough (pholcodine 1 mg / 1 mL) oral liquid solution, 30 mL (trade product pack) Unknown Cell Type 2
Actifed CC Dry Cough (pholcodine 1 mg / 1 mL) oral liquid solution, 30 mL, bottle (containered trade product pack) Unknown Cell Type 2
Actifed CC Dry Cough 1 mg/mL oral liquid solution Unknown Cell Type 2
Actifed CC Dry Cough 1 mg/mL oral liquid solution, 200 mL Unknown Cell Type 2
Actifed CC Dry Cough 1 mg/mL oral liquid solution, 200 mL, bottle Unknown Cell Type 2
Actifed CC Dry Cough 1 mg/mL oral liquid solution, 30 mL Unknown Cell Type 2
Actifed CC Dry Cough 1 mg/mL oral liquid solution, 30 mL, bottle Unknown Cell Type 2
Actilax (lactulose 3.34 g / 5 mL) oral liquid solution, 5 mL measure (trade product unit of use) Unknown Cell Type 2
Actilax (lactulose 3.34 g / 5 mL) oral liquid solution, 500 mL (trade product pack) Unknown Cell Type 2
Actilax (lactulose 3.34 g / 5 mL) oral liquid solution, 500 mL, bottle (containered trade product pack) Unknown Cell Type 2
Actilax 3.34 g/5 mL oral liquid, 5 mL Actilax 3.3 g/5 mL oral liquid, 5 mL
Actilax 3.34 g/5 mL oral liquid, 500 mL Actilax 3.3 g/5 mL oral liquid, 500 mL
Actilax 3.34 g/5 mL oral liquid, 500 mL, bottle Actilax 3.3 g/5 mL oral liquid, 500 mL, bottle
Actilax 3.34 g/5 mL oral liquid solution, 5 mL Unknown Cell Type 2
Actilax 3.34 g/5 mL oral liquid solution, 500 mL Unknown Cell Type 2
Actilax 3.34 g/5 mL oral liquid solution, 500 mL, bottle Unknown Cell Type 2
Actinobacillus actinomycetem comitans Aggregatibacter actinomycetemcomitans

Start Previous Page 16 of 1313 Next End


Reference Sets

Australian dialect reference set

Unit of use quantity reference set

Reference set descriptor

Back to Start